Cara Therapeutics reported $-0.72 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Cara Therapeutics USD -0.72 0.14 Mar/2026
Cassava Sciences USD -0.18 0.04 Jun/2026
Chugai Pharma JPY 87.23 16.54 Sep/2026
Cipla INR 10.85 1.09 Sep/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.07 0.16 Jun/2026
CSL USD 5.07 3 Dec/2025
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Pacira USD 0.28 0.45 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
RedHill Biopharma USD -1.31 33.38 Jun/2024
Supernus Pharmaceuticals USD 0.35 1.36 Sep/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024